RO120195B1 - Aminobenzofenone ca inhibitori de interleukină şi tnf - Google Patents

Aminobenzofenone ca inhibitori de interleukină şi tnf Download PDF

Info

Publication number
RO120195B1
RO120195B1 RO99-00839A RO9900839A RO120195B1 RO 120195 B1 RO120195 B1 RO 120195B1 RO 9900839 A RO9900839 A RO 9900839A RO 120195 B1 RO120195 B1 RO 120195B1
Authority
RO
Romania
Prior art keywords
compound
raw material
nmr
general method
purification
Prior art date
Application number
RO99-00839A
Other languages
English (en)
Romanian (ro)
Inventor
Erik Rytter Ottosen
Rachlin Schneur
Original Assignee
Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) filed Critical Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab)
Publication of RO120195B1 publication Critical patent/RO120195B1/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RO99-00839A 1997-01-24 1998-01-08 Aminobenzofenone ca inhibitori de interleukină şi tnf RO120195B1 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9701453.4A GB9701453D0 (en) 1997-01-24 1997-01-24 Aminobenzophenones
PCT/DK1998/000008 WO1998032730A1 (en) 1997-01-24 1998-01-08 Aminobenzophenones as inhibitors of interleukin and tnf

Publications (1)

Publication Number Publication Date
RO120195B1 true RO120195B1 (ro) 2005-10-28

Family

ID=10806523

Family Applications (1)

Application Number Title Priority Date Filing Date
RO99-00839A RO120195B1 (ro) 1997-01-24 1998-01-08 Aminobenzofenone ca inhibitori de interleukină şi tnf

Country Status (19)

Country Link
US (1) US6313174B1 (cg-RX-API-DMAC10.html)
EP (1) EP0966424B1 (cg-RX-API-DMAC10.html)
JP (1) JP4250204B2 (cg-RX-API-DMAC10.html)
KR (1) KR100544046B1 (cg-RX-API-DMAC10.html)
CN (1) CN1188388C (cg-RX-API-DMAC10.html)
AT (1) ATE269844T1 (cg-RX-API-DMAC10.html)
AU (1) AU733561B2 (cg-RX-API-DMAC10.html)
CA (1) CA2278798C (cg-RX-API-DMAC10.html)
DE (1) DE69824705T2 (cg-RX-API-DMAC10.html)
DK (1) DK0966424T3 (cg-RX-API-DMAC10.html)
ES (1) ES2223116T3 (cg-RX-API-DMAC10.html)
GB (1) GB9701453D0 (cg-RX-API-DMAC10.html)
HU (1) HUP0000678A3 (cg-RX-API-DMAC10.html)
NZ (1) NZ336754A (cg-RX-API-DMAC10.html)
PL (1) PL334806A1 (cg-RX-API-DMAC10.html)
PT (1) PT966424E (cg-RX-API-DMAC10.html)
RO (1) RO120195B1 (cg-RX-API-DMAC10.html)
RU (1) RU2200153C2 (cg-RX-API-DMAC10.html)
WO (1) WO1998032730A1 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE277889T1 (de) * 1999-07-16 2004-10-15 Leo Pharma As Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha
KR20020022774A (ko) * 1999-07-16 2002-03-27 룬딩 에른스트 IL-1β 및 TNF-α 억제제로서의 아미노벤조페논
PT1210320E (pt) * 1999-07-16 2005-01-31 Leo Pharma As Aminobenzofenonas como inibidores de il-1beta e tnf-alfa
RU2247719C2 (ru) * 1999-07-16 2005-03-10 Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) Аминобензофеноны как ингибиторы il-1 бета и tnf-альфа, фармацевтическая композиция и способ лечения и/или профилактики воспалительных заболеваний
ES2204639T3 (es) * 1999-07-16 2004-05-01 Leo Pharma A/S Nuevas aminobenzofeonas.
US6897236B1 (en) 1999-07-16 2005-05-24 Leo Pharmaceutical Products, Ltd. Aminobenzophenones as inhibitors of IL-1β and TNF-α
KR20020071876A (ko) * 1999-12-06 2002-09-13 레오 파마 에이/에스 IL-1β 및 TNF-α의 억제제로서의 아미노벤조페논
CA2393027A1 (en) * 1999-12-17 2001-06-21 Abbott Laboratories Inhibitors of interleukin 5 gene expression
CA2396693A1 (en) * 1999-12-28 2001-07-05 Stephen T. Wrobleski Cytokine, especially tnf-alpha, inhibitors
CN1239485C (zh) * 2000-05-22 2006-02-01 里奥制药有限公司 作为IL-1β和TNF-α抑制剂的二苯酮类
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
SE0100569D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab New compounds
GB0107368D0 (en) * 2001-03-23 2001-05-16 Novartis Ag Organic compounds
US20030073832A1 (en) * 2001-04-10 2003-04-17 Havez Sophie Elisabeth Novel aminophenyl ketone derivatives
JP4540984B2 (ja) * 2001-08-28 2010-09-08 レオ ファーマ アクティーゼルスカブ 新規アミノベンゾフェノン
RU2005122951A (ru) * 2002-12-20 2006-01-27 Лео Фарма А/С (Dk) Новые аминобензофеноновые соединения
RU2396250C2 (ru) 2003-07-24 2010-08-10 Лео Фарма А/С Новые производные аминобензофенона
EP1828148B1 (en) 2004-12-13 2010-01-20 Leo Pharma A/S Triazole substituted aminobenzophenone compounds
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
KR101057546B1 (ko) * 2007-06-05 2011-08-17 주식회사 엘지화학 광학 이방성 화합물 및 이를 포함하는 수지 조성물
EP2206534A1 (de) 2008-10-09 2010-07-14 c-a-i-r biosciences GmbH Dibenzocycloheptanonderivate und pharmazeutische Mittel, welche diese Verbindungen enthalten
WO2012167133A2 (en) * 2011-06-01 2012-12-06 The Regents Of The University Of California Inhibitors of anandamide transport and their therapeutic uses
JP6092870B2 (ja) 2011-08-19 2017-03-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア メタ置換ビフェニル末梢に限局されたfaah阻害剤
ES2908240T3 (es) 2014-04-07 2022-04-28 Univ California Inhibidores de la enzima amida hidrolasa de ácidos grasos (FAAH) con biodisponibilidad oral mejorada y su uso como medicamentos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1535401A (en) * 1977-07-28 1978-12-13 Holliday & Co Ltd L Nitrodiphenylamine carboxylic acid disperse dyes
SU790620A1 (ru) * 1979-06-01 1981-07-30 Ордена Трудового Красного Знамени Институт Медицинскойпаразитологии И Торпической Медицины Им.E.И.Марциновского Дихлор аминобензофенон как исходный продуктдл пОлучЕНи лЕКАРСТВЕННыХ пРЕпАРАТОВ C АНТигЕльМиНТНыМдЕйСТВиЕМ
JPH0776303B2 (ja) * 1986-11-21 1995-08-16 株式会社リコー 呈色性フタリド化合物及びその製造法及びこのものを発色成分とした記録材料

Also Published As

Publication number Publication date
JP4250204B2 (ja) 2009-04-08
DE69824705D1 (de) 2004-07-29
CN1188388C (zh) 2005-02-09
JP2001511771A (ja) 2001-08-14
KR100544046B1 (ko) 2006-01-23
AU5478198A (en) 1998-08-18
NZ336754A (en) 2001-03-30
KR20000070437A (ko) 2000-11-25
DE69824705T2 (de) 2005-07-07
HUP0000678A3 (en) 2001-11-28
EP0966424B1 (en) 2004-06-23
RU2200153C2 (ru) 2003-03-10
EP0966424A1 (en) 1999-12-29
HUP0000678A2 (hu) 2001-10-28
PT966424E (pt) 2004-09-30
AU733561B2 (en) 2001-05-17
CA2278798A1 (en) 1998-07-30
HK1025306A1 (en) 2000-11-10
PL334806A1 (en) 2000-03-13
WO1998032730A1 (en) 1998-07-30
ATE269844T1 (de) 2004-07-15
CN1248966A (zh) 2000-03-29
US6313174B1 (en) 2001-11-06
DK0966424T3 (da) 2004-11-01
GB9701453D0 (en) 1997-03-12
CA2278798C (en) 2007-07-03
ES2223116T3 (es) 2005-02-16

Similar Documents

Publication Publication Date Title
JP4250204B2 (ja) インターロイキンおよびtnfの阻害剤としてのアミノベンゾフェノン類
KR100395280B1 (ko) 신규한3환성화합물및그를함유하는의약조성물
US6555710B1 (en) Aminobenzophenones as inhibitors of IL-1 β and TNF-α
JP5450105B2 (ja) ビフェニル−4−イル−スルホン酸アリールアミド及びその治療剤としての使用
RU2240995C2 (ru) Аминобензофеноны в качестве ингибиторов интерлейкина il-1бета и фактора некроза опухолей tnf-альфа
HUP0201846A2 (en) Amonobenzophenones as inhibitors of il-1betha and tnf-alpha and pharmaceutical compositions containing them
US6750253B1 (en) Aminobenzophenones as inhibitors of il-1β and tnf-α
EP1202954B1 (en) Novel aminobenzophenones
EP1366021B1 (en) Substituted diarylureas as stimulators for fas-mediated apoptosis
CZ259899A3 (cs) Aminobenzofenony jako inhibitory interleukinu a TNF
PL178458B1 (pl) Kompozycja farmaceutyczna do leczenia nowotworów lub chorób powstających w skutek nieprawidłowej i nadmiernej proliferacji komórek
US6008251A (en) Retinoid-like compounds